INS and Alzheimer disease: Brain insulin signaling is dysregulated in AD brain (Steen et al., 2005; Liu et al., 2011), and this dysregulation appears to contribute to impaired brain glucose metabolism (Chen et al., 2014), a well-established metabolic abnormality that precedes AD and is likely involved in neurodegeneration in AD.